Basic aspects of the management of the diabetic patient and COVID-19
Welcome to the Online Course Basics of Diabetic Patient Management and COVID-19!
The high association of T2DM with COVID-19 infection and its complications has been seen from many points of view. This association is based on multiple factors that go through the high association that DM presents with other risk factors for infection such as hypertension and obesity, in addition to the consequent cardiovascular diseases.
The alteration of the innate immunity that diabetics present confers a higher risk of infection. The relationship with the angiotensin II receptor, which uses cells from different tissues as a gateway, making this infection a pathology that is not exclusively limited to the airways. The pancreatic involvement is notable due to direct cytoxicity of the ß cell, its ability to aggravate the low-grade infection already present in diabetics, in addition to triggering a release of cytokines: high amounts of IL-6, IL-1ß, necrosis factor tumor to (TNFa), monocyte chemoattractant protein-1 (MCP-1), with an uncontrolled hyperinflammatory systemic response. It should be noted that in the diabetic patient another risk factor is added, because in the midst of an underlying hypercoagulant / pro-thrombotic state predisposed by the mere presence of DM2, there is an over-activation of the coagulation cascade in COVID-19 that can lead to fatal thromboembolic complications and increased mortality as seen.
To answer many of the questions that have been raised and are raised in diabetic patients with COVID-19 infection. The course starts from a pathophysiological analysis that helps to understand the greater morbidity and mortality of diabetic patients, to make way for seven modules in video format that explain the most important aspects of the affection of the diabetic patient.
* In the Preview tab, you will find a video explaining the registration process for the course and the presentation by Dr. Pablo Miramontes.
MODULE 1: Presentation of the course. Diabetes and COVID-19 from pathophysiology to prognosis. Dr. Pablo Miramontes González | Coordinator
MODULE 2: Association of hospital hyperglycemia in infection. COVID-19. Transition to discharge. Dr. Fco. Javier Carrasco Sánchez | Coordinator
MODULE 3: Therapeutic approach to the COVID-19 patient with DM2. Dr. Pablo Pérez Martínez
MODULE 4: Diabetes and cardiovascular disease in COVID-19 infection. Dr. José María Fernández Rodríguez
MODULE 5: Heart failure and diabetes in COVID-19. Dr. Leopoldo Pérez de Isla
MODULE 6: Obesity in the COVID-19 pandemic. Dr. Juana Carretero Gómez
MODULE 7: Basic nutrition in the COVID-19 patient. Dr. Fernando Garrachón Vallo
MODULE 8: The diabetic patient with COVID-19 who does not require hospitalization. Dr. Enrique Carretero Anibarro
Dr. Pablo Miramontes GonzálezAdjunto en el Servicio de Medicina Interna
H. U. Río Hortega, Valladolid
Dr. Fco. Javier Carrasco SánchezAdjunto de Medicina Interna
Hospital Juan Ramón Jiménez, Huelva
Dr. Pablo Pérez MartínezCatedrático de Medicina Interna
Hospital Universitario Reina Sofía, Córdoba
Dr. José María Fernández RodríguezAdjunto en el Servicio de Medicina Interna
Hospital de Cangas de Narcea
Dr. Leopoldo Pérez de IslaJefe de la Unidad de Imagen Cardiovascular
Hospital Clínico San Carlos, Madrid
Dra. Juana Carretero GómezMédico especialista en Medicina Interna
Hospital Comarcal, Zafra
Dr. Fernando Garrachón ValloMédico especialista en Medicina Interna
Hospital Universitario Virgen Macarena, Sevilla
Dr. Enrique Carretero AnibarroMédico de Familia
Servicio Andaluz de Salud